The Insomnia Treatment Market To Grow Incessantly At A CAGR Of 5.2%Posted by Ashish on March 24th, 2021 Technological innovations have revolutionized lifestyle, communication, business, travel, and healthcare. The healthcare technology industry is continually improving ways to treat neural-related medical conditions, coupled with a significant understanding of subsequent ramifications and consequences. On the other hand, the pharmaceutical landscape has also transitioned and opened itself to explore novel scientific approaches and innovative technologies within its core therapeutic areas. New Pharmaceutical Innovations to Address Key Concerns for Sleep Medications In the 32nd Annual Meeting of the Associated Professional Sleep Societies (SLEEP 2018), Eisai Co., Ltd. and Purdue Pharma L.P showed positive results from clinical trials of lemborexant, which is currently being studied for the potential treatment of multiple sleep disorders, especially insomnia. On examining lemborexant for sleep onset, sleep maintenance, and return to sleep latency, it showed favorable results in terms of postural instability and residual effect compared to placebo and zolpidem (Ambien). Strategizing The Moves For The Next Decade? See Through Sample Of Insomnia Treatment Market Report! https://www.persistencemarketresearch.co/samples/23203 Company Profiles
Like it? Share it! More by this author |